Owlet Inc ( (OWLT) ) has released its Q3 earnings. Here is a breakdown of the information Owlet Inc presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Owlet Inc., a leader in smart infant monitoring technology, provides innovative health solutions for parents through FDA-authorized pediatric wearables and data insights.
Owlet Inc. announced its financial results for the third quarter of 2024, showcasing significant revenue growth and improved margins, signaling a strong performance in the infant monitoring sector.
The company’s revenue for Q3 2024 reached $22.1 million, marking a 141% increase compared to the same quarter last year, driven by robust sales of its Dream Sock products. Owlet’s gross margin improved significantly to 52.2%, reflecting higher revenue and favorable product mix. Additionally, the company reported a positive adjusted EBITDA of $0.6 million, an improvement of $6.1 million from the previous year. Despite these gains, Owlet maintained a net loss of $5.6 million, consistent with the prior year’s results. Strategic financial maneuvers such as a follow-on equity offering and debt refinancing have bolstered the company’s operational flexibility.
Owlet’s management remains optimistic, focusing on capitalizing on growth opportunities within its core products and the potential of its BabySat medical offering. The company is well-positioned to deliver added value to its stakeholders and aims to end the year on a strong note.
Looking ahead, Owlet expects its net revenue for the full year 2024 to be between $74 million and $77.5 million, with gross margins of 48% to 49%, highlighting a positive outlook for continued growth and market expansion.
